# Glenmark Pharmaceuticals Technical Analysis Report
**Stock:** Glenmark Pharmaceuticals Limited (NSE)
**Current Price:** ₹2,038.20
**Date:** December 23, 2024
**Timeframe:** Weekly Chart
## Price Action Overview
Glenmark Pharmaceuticals is currently trading at ₹2,038.20, showing strong momentum with a 2.31% gain. The stock has demonstrated significant recovery from its mid-2024 lows and is currently testing critical resistance levels.
## Technical Structure
The chart reveals a well-defined technical pattern with the following characteristics:
**Support and Resistance Levels:**
- Strong horizontal support at ₹1,790.65 (marked in black) has held multiple times
- Target 1 (Tgt 1) at ₹2,132.50 represents immediate resistance
- Target 2 (Tgt 2) at ₹2,225.50 marks the next major resistance zone
**Trend Analysis:**
The stock exhibits a clear recovery pattern from the March-April 2025 lows around ₹1,400-1,500. After testing support near ₹1,790, the price has bounced strongly and is now approaching the first target level. The presence of multiple moving averages (likely including 20, 50, and 200-period) suggests the stock is in a recovery phase, with shorter-term averages crossing above longer-term ones.
**Pattern Recognition:**
The descending trendline (shown in black) from the September 2024 peak has been broken to the upside, which is a bullish technical signal. This breakout suggests potential continuation of the upward momentum.
## Key Observations
**Bullish Factors:**
- Recent breakout above the descending trendline
- Price holding above the ₹1,790 support zone
- Positive price action with higher lows being formed
- Current momentum showing +2.31% gain
**Resistance Zones:**
- Immediate resistance at ₹2,132.50 (Target 1)
- Major resistance at ₹2,225.50 (Target 2)
- Historical resistance zone around ₹2,300-2,400 from earlier in 2024
**Critical Levels to Watch:**
- Support: ₹1,790.65 (crucial support level)
- Current: ₹2,038.20
- Resistance: ₹2,132.50 and ₹2,225.50
## Outlook
The technical setup suggests a bullish bias as long as the stock maintains above the ₹1,790 support level. The breakout from the descending trendline and the current price position indicate potential for further upside toward the marked targets. However, traders should watch for potential resistance at the Target 1 level around ₹2,132.50.
A sustained move above ₹2,132.50 could open the path toward ₹2,225.50, while a failure to break through this level might lead to consolidation or a pullback toward the ₹1,900-2,000 zone.
---
*This analysis is based on technical chart patterns and should not be considered as financial advice. Please conduct your own research and consult with a financial advisor before making investment decisions.*
**Stock:** Glenmark Pharmaceuticals Limited (NSE)
**Current Price:** ₹2,038.20
**Date:** December 23, 2024
**Timeframe:** Weekly Chart
## Price Action Overview
Glenmark Pharmaceuticals is currently trading at ₹2,038.20, showing strong momentum with a 2.31% gain. The stock has demonstrated significant recovery from its mid-2024 lows and is currently testing critical resistance levels.
## Technical Structure
The chart reveals a well-defined technical pattern with the following characteristics:
**Support and Resistance Levels:**
- Strong horizontal support at ₹1,790.65 (marked in black) has held multiple times
- Target 1 (Tgt 1) at ₹2,132.50 represents immediate resistance
- Target 2 (Tgt 2) at ₹2,225.50 marks the next major resistance zone
**Trend Analysis:**
The stock exhibits a clear recovery pattern from the March-April 2025 lows around ₹1,400-1,500. After testing support near ₹1,790, the price has bounced strongly and is now approaching the first target level. The presence of multiple moving averages (likely including 20, 50, and 200-period) suggests the stock is in a recovery phase, with shorter-term averages crossing above longer-term ones.
**Pattern Recognition:**
The descending trendline (shown in black) from the September 2024 peak has been broken to the upside, which is a bullish technical signal. This breakout suggests potential continuation of the upward momentum.
## Key Observations
**Bullish Factors:**
- Recent breakout above the descending trendline
- Price holding above the ₹1,790 support zone
- Positive price action with higher lows being formed
- Current momentum showing +2.31% gain
**Resistance Zones:**
- Immediate resistance at ₹2,132.50 (Target 1)
- Major resistance at ₹2,225.50 (Target 2)
- Historical resistance zone around ₹2,300-2,400 from earlier in 2024
**Critical Levels to Watch:**
- Support: ₹1,790.65 (crucial support level)
- Current: ₹2,038.20
- Resistance: ₹2,132.50 and ₹2,225.50
## Outlook
The technical setup suggests a bullish bias as long as the stock maintains above the ₹1,790 support level. The breakout from the descending trendline and the current price position indicate potential for further upside toward the marked targets. However, traders should watch for potential resistance at the Target 1 level around ₹2,132.50.
A sustained move above ₹2,132.50 could open the path toward ₹2,225.50, while a failure to break through this level might lead to consolidation or a pullback toward the ₹1,900-2,000 zone.
---
*This analysis is based on technical chart patterns and should not be considered as financial advice. Please conduct your own research and consult with a financial advisor before making investment decisions.*
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.